Lung Cancers Recruiting Phase 4 Trials for Ipilimumab (DB06186)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02869789An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced CancersTreatment